Emergency departments (ED) are challenged by increasing patient visits, overcrowding and prolonged length of stay (LOS). The cause of these problems is multifactorial. Delays in the laboratory are often perceived as contributing to delays in care and increased LOS. Implementation of selected point-of-care tests in...

Abdominal aortic aneurysms (AAAs) are currently identified by incidental imaging or ultrasound screening. The potential diagnostic and prognostic value of D-dimer for AAA was assessed in this study. 1260 men from a population-based ultrasound screening study were included, of which 299 had small AAAs monitored by...

Postoperative cardiovascular event including myocardial infarction or heart failure is a major cause of morbidity after non-cardiac surgery. Preoperative evaluation including estimation of the probability of perioperative cardiac event and application of non-invasive testing or beta-blocker has been developed, but...

Hemodialysis and related treatments for those with failing kidneys all involve blood flow through a circuit outside the body. This extracorporeal circuit - the dialysis machine and its connections from and back to the body - is a non-physiological, pro-coagulant environment.  To counter the tendency for patients'...

The process of patient sample testing, whether performed in the clinical laboratory or at the point of care, is the sum of three distinct phases. The first is the preanalytical phase, which includes test selection as well as sample collection and handling.  The second is the analytical or measuring phase that...

As healthcare seeks to provide better care with fewer resources, Point-of-Care Testing steps in to move key diagnostic or screening tests to the patient’s bedside. The results can have a significant impact on a patient outcome and operational costs.

Clinical laboratory measurement of serum/plasma creatinine concentration has been used to assess patient kidney function for well over 50 years.  With the incorporation of creatinine analyses to blood gas and other point-of-care platforms the test is now available outside the laboratory, at the bedside and in the...

Some of the frequently asked questions are: Should we use BE (base excess) or SID (strong ion difference) as a measure of a metabolic acid-base disturbance?  Is there any difference between BB (buffer base) and SID? Should we use SBE (standard base excess), i.e. BE referring to the expanded extracellular fluid or...

Clinical laboratory measurement of serum/plasma creatinine concentration has been used to assess patient kidney function for well over 50 years. With incorporation of creatinine analyses to blood gas and other point-of-care platforms the test is now available outside the laboratory, at the bedside and in the clinic.  ...

Analytical methods are often developed at one site and transferred to other sites for routine use. Increasingly, the method development is made by manufacturers of instruments and reagents. Regulatory agencies have ruled that the responsibility for the performance of IVDs in the laboratories mainly should lie with...